Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-24

Clinical Trial Update: FST-100 in the Treatment of Acute Viral Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FST-100 in acute viral conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FST-100

Snippet

Sponsor: Shire | Conditions: Acute Viral Conjunctivitis | Phase 2 | Status: COMPLETED